filmov
tv
Progressive MS | EAN 2020 summary by Multiple Sclerosis Academy

Показать описание
Speakers: Dr Wallace Brownlee and Dr Kate Petheram
#EAN2020
This year’s European Academy of Neurology Congress took place from May 23rd-26th and was the first of its kind to be entirely virtual.
This activity has been sponsored by Roche Products Limited. Roche Products Limited has had no control over the educational content of this activity.
Progressive MS | EAN 2020 summary by Multiple Sclerosis Academy
Progressive MS & Starting and switching DMTs – part 2 | EAN 2020 summary by MS Academy
Starting & switching DMTs | EAN 2020 summary by Multiple Sclerosis Academy
EAN 2020: Introduction and reflections on a virtual congress | Multiple Sclerosis Academy
Scott Newsome, DO, MSCS, FAAN: Progressive MS: The 2020 Whitaker Lecture
Crucial findings in progressive MS
Bianca Weinstock-Guttman, EAN 2020 – CHORDS Study in RRMS With Suboptimal Prior Response to DMTs
Updated guidelines for palliative care in advanced MS
Ask an MS Expert: Living Well with Progressive MS
How are Outcomes of Progressive MS Measured?
Siponimod – how do we give patients with secondary progressive MS hope? | MS Academy
Neuroregenerative agents in progressive multiple sclerosis
CMSC 2020 Day 1: Patricia Coyle, MD on Progressive MS: Dx, Clinical Course and Long-Term Management
Discovering Life-Changing Treatments for People with Progressive MS
Answering today’s big questions in progressive MS
BTK inhibitors for multiple sclerosis: progressive disease and de-escalation
Future challenges for MS research: progressive disease
Le Hua, MD: Siponimod in Secondary Progressive Multiple Sclerosis
AttackMS, or: What does treating MS early mean in clinical practice? | MS Academy Webinar
Options in the Pipeline for Progressive MS
Future directions for progressive multiple sclerosis
Current treatments for primary and secondary progressive multiple sclerosis
Stephen L. Hauser, MD: Fenebrutinib and BTK Inhibiton in Progressive MS
Symptom management and well-being in progressive MS panel discussion
Комментарии